María García-Fortes

10PUBLICATIONS
100CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursOtorhinolaryngologyGene expression (incl. microarray and other genome-wide approaches)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 08, 2026
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study.

|May 07, 2026
Impact of molecular profiling in patients with acute myeloid leukemia undergoing allogeneic transplantation in first remission: a study by the PETHEMA group.

|Apr 22, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.

|Feb 11, 2026
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.

Gaspar Aspas Requena, Pau Montesinos, Emilie Bérard

|Jun 13, 2025
From Sanger to Oxford Nanopore MinION Technology: The Impact of Third-Generation Sequencing on Genetic Hematological Diagnosis.

María José Larráyoz, Pablo Luri-Martin, Amagoia Mañu

|Mar 13, 2025
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study.

Blanca Boluda, Rebeca Rodriguez-Veiga, Claudia Sargas

Pageof 2

Frequent Collaborators

6 joint publications

David Martínez-Cuadrón

6 joint publications

Pau Montesinos

5 joint publications

Joaquín Martínez-López

5 joint publications

Teresa Bernal Del Castillo